Induction Healthcare Group (INHC) Competitors GBX 8.25 -0.25 (-2.94%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades INHC vs. RENX, COG, FDBK, IQAI, DVRG, TRLS, SENS, EMIS, CRW, and INSShould you be buying Induction Healthcare Group stock or one of its competitors? The main competitors of Induction Healthcare Group include Renalytix (RENX), Cambridge Cognition (COG), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), and Instem (INS). These companies are all part of the "health information services" industry. Induction Healthcare Group vs. Renalytix Cambridge Cognition Feedback IQ-AI DeepVerge Trellus Health Sensyne Health EMIS Group Craneware Instem Induction Healthcare Group (LON:INHC) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation, community ranking and media sentiment. Which has higher valuation and earnings, INHC or RENX? Induction Healthcare Group has higher revenue and earnings than Renalytix. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInduction Healthcare Group£13.65M0.57-£3.25M-£0.03-275.00Renalytix£2.29M5.80-£33.46M-£0.24-33.33 Does the media favor INHC or RENX? In the previous week, Induction Healthcare Group's average media sentiment score of 0.44 beat Renalytix's score of 0.00 indicating that Induction Healthcare Group is being referred to more favorably in the media. Company Overall Sentiment Induction Healthcare Group Neutral Renalytix Neutral Do analysts rate INHC or RENX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Induction Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ARenalytix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community prefer INHC or RENX? Renalytix received 9 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 74.19% of users gave Renalytix an outperform vote. CompanyUnderperformOutperformInduction Healthcare GroupOutperform Votes1493.33% Underperform Votes16.67%RenalytixOutperform Votes2374.19% Underperform Votes825.81% Is INHC or RENX more profitable? Renalytix has a net margin of 0.00% compared to Induction Healthcare Group's net margin of -23.86%. Induction Healthcare Group's return on equity of -14.53% beat Renalytix's return on equity.Company Net Margins Return on Equity Return on Assets Induction Healthcare Group-23.86% -14.53% -7.32% Renalytix N/A -1,073.18%-93.54% Which has more risk & volatility, INHC or RENX? Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500. Do insiders & institutionals have more ownership in INHC or RENX? 46.3% of Induction Healthcare Group shares are owned by institutional investors. Comparatively, 28.4% of Renalytix shares are owned by institutional investors. 54.6% of Induction Healthcare Group shares are owned by insiders. Comparatively, 35.7% of Renalytix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryInduction Healthcare Group beats Renalytix on 9 of the 14 factors compared between the two stocks. Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). Get Induction Healthcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INHC vs. The Competition Export to ExcelMetricInduction Healthcare GroupHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£7.74M£218.32M£5.40B£1.59BDividend YieldN/A6.58%5.13%11.05%P/E Ratio-275.00652.83113.461,740.37Price / Sales0.57338.721,484.40230,520.65Price / Cash2.6843.5739.6435.87Price / Book0.384.924.652.88Net Income-£3.25M-£5.00M£119.06M£144.83M7 Day Performance10.00%0.53%0.79%0.11%1 Month Performance10.00%-1.12%5.65%-0.11%1 Year PerformanceN/A10.97%36.76%15.28% Induction Healthcare Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INHCInduction Healthcare GroupN/AGBX 8.25-2.9%N/A-67.3%£7.74M£13.65M-275.0074Gap DownRENXRenalytixN/AGBX 8.10+1.3%N/A-81.8%£13.44M£2.29M-33.75102Gap UpCOGCambridge CognitionN/AGBX 29+3.6%N/A-57.6%£12.16M£13.08M-725.0080News CoverageFDBKFeedbackN/AGBX 49flatN/A-42.1%£6.53M£1.02M-188.4624Gap UpIQAIIQ-AIN/AGBX 0.95-7.3%N/A-75.6%£2.11M£538,190.00-13.676Gap UpDVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.68flatN/A-87.1%£1.09M£35,000.00-22.5031Gap DownSENSSensyne HealthN/AGBX 0.35-33.3%N/A+0.0%£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AGBX 1,920flatN/A+0.0%£1.23B£176.86M4,085.111,560CRWCraneware2.3159 of 5 starsGBX 1,720+1.2%GBX 2,700+57.0%+23.7%£607.85M£189.27M6,615.38734INSInstemN/AGBX 830flatN/A+8.5%£199.62M£61.63M5,928.57500 Related Companies and Tools Related Companies Renalytix Alternatives Cambridge Cognition Alternatives Feedback Alternatives IQ-AI Alternatives DeepVerge Alternatives Trellus Health Alternatives Sensyne Health Alternatives EMIS Group Alternatives Craneware Alternatives Instem Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:INHC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Induction Healthcare Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Induction Healthcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
